Total Payments
$1,283
2024 Payments
$393.02
Companies
18
Transactions
63
Medicare Patients
8,540
Medicare Billing
$667,315
Payment Breakdown by Category
Food & Beverage$1,151 (89.7%)
Education$131.99 (10.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,151 | 61 | 89.7% |
| Education | $131.99 | 2 | 10.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $396.84 | 21 | $0 (2024) |
| Janssen Biotech, Inc. | $248.89 | 8 | $0 (2024) |
| LEO Pharma Inc. | $162.39 | 9 | $0 (2021) |
| GENZYME CORPORATION | $60.37 | 3 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $53.74 | 2 | $0 (2021) |
| Regeneron Healthcare Solutions, Inc. | $51.07 | 3 | $0 (2021) |
| Amgen Inc. | $42.12 | 2 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $39.65 | 2 | $0 (2019) |
| PFIZER INC. | $39.45 | 2 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $36.94 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $393.02 | 23 | ABBVIE INC. ($172.81) |
| 2023 | $240.06 | 5 | ABBVIE INC. ($164.78) |
| 2022 | $111.47 | 6 | Janssen Biotech, Inc. ($69.45) |
| 2021 | $252.86 | 14 | LEO Pharma Inc. ($77.05) |
| 2020 | $36.99 | 2 | AbbVie Inc. ($20.75) |
| 2019 | $52.71 | 3 | Ortho Dermatologics, a division of Bausch Health US, LLC ($19.91) |
| 2018 | $150.29 | 7 | LEO Pharma Inc. ($56.34) |
| 2017 | $45.29 | 3 | GENZYME CORPORATION ($18.70) |
All Payment Transactions
63 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/12/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: Inflammation | ||||||
| 11/05/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: IMMUNOLOGY | ||||||
| 10/28/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $7.82 | General |
| 10/28/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $2.23 | General |
| 10/08/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $4.70 | General |
| Category: IMMUNOLOGY | ||||||
| 09/12/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: DERMATOLOGY | ||||||
| 09/10/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: IMMUNOLOGY | ||||||
| 09/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $12.74 | General |
| Category: IMMUNOLOGY | ||||||
| 08/15/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.56 | General |
| Category: IMMUNOLOGY | ||||||
| 08/07/2024 | Verrica Pharmaceuticals Inc. | YCANTH (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: DERMATOLOGY | ||||||
| 07/31/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $11.67 | General |
| Category: IMMUNOLOGY | ||||||
| 07/23/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: Inflammation | ||||||
| 06/26/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: IMMUNOLOGY | ||||||
| 06/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: Immunology | ||||||
| 05/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $72.00 | General |
| Category: Immunology | ||||||
| 04/23/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $7.24 | General |
| Category: IMMUNOLOGY | ||||||
| 04/05/2024 | ABBVIE INC. | HUMIRA (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: IMMUNOLOGY | ||||||
| 04/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: Immunology | ||||||
| 04/02/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $11.96 | General |
| Category: IMMUNOLOGY | ||||||
| 04/02/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $5.84 | General |
| Category: IMMUNOLOGY | ||||||
| 03/01/2024 | ABBVIE INC. | HUMIRA (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: IMMUNOLOGY | ||||||
| 03/01/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.28 | General |
| Category: IMMUNOLOGY | ||||||
| 01/19/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 12/14/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $122.36 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $59.99 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 2,430 | 4,353 | $828,610 | $189,567 |
| 2022 | 16 | 2,245 | 4,258 | $790,115 | $178,680 |
| 2021 | 17 | 2,271 | 4,181 | $782,655 | $182,251 |
| 2020 | 15 | 1,594 | 2,665 | $495,985 | $116,818 |
Total Patients
8,540
Total Services
15,457
Medicare Billing
$667,315
Procedure Codes
67
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 2 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 155 | 197 | $29,550 | $8,498 | 28.8% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 48 | 63 | $23,625 | $8,467 | 35.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 117 | 117 | $29,250 | $8,450 | 28.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 76 | 89 | $20,025 | $8,172 | 40.8% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 14 | 15 | $17,475 | $3,683 | 21.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 47 | 66 | $11,550 | $2,885 | 25.0% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2022 | 21 | 42 | $9,450 | $1,739 | 18.4% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 21 | 21 | $4,725 | $889.76 | 18.8% |
| Q0112 | All potassium hydroxide (koh) preparations | Office | 2022 | 26 | 28 | $1,120 | $160.72 | 14.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 22 | 54 | $540.00 | $46.54 | 8.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 657 | 909 | $181,455 | $60,099 | 33.1% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 201 | 256 | $128,000 | $22,631 | 17.7% |
| 17000 | Destruction of skin growth | Office | 2021 | 345 | 471 | $141,300 | $20,194 | 14.3% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 209 | 253 | $88,550 | $19,293 | 21.8% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 119 | 119 | $30,025 | $9,800 | 32.6% |
| 17262 | Destruction of malignant growth (1.1 to 2.0 centimeters) of trunk, arms, or legs | Office | 2021 | 47 | 62 | $21,700 | $8,563 | 39.5% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 257 | 1,536 | $76,800 | $8,481 | 11.0% |
| 17004 | Destruction of 15 or more premalignant skin growths | Office | 2021 | 52 | 64 | $24,000 | $8,480 | 35.3% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 161 | 198 | $30,000 | $8,416 | 28.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 50 | 65 | $14,875 | $5,693 | 38.3% |
| 11103 | Tangential biopsy of additional skin lesion | Office | 2021 | 55 | 69 | $12,075 | $3,201 | 26.5% |
| 12032 | Repair of wound (2.6 to 7.5 centimeters) of the scalp, underarms, trunk, arms, and/or legs | Office | 2021 | 11 | 11 | $11,960 | $2,788 | 23.3% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 38 | 38 | $8,640 | $2,183 | 25.3% |
| 11900 | Injection of up to 7 skin growths | Office | 2021 | 16 | 37 | $8,325 | $1,525 | 18.3% |
| 11200 | Removal of up to and including 15 skin tags | Office | 2021 | 12 | 14 | $3,500 | $706.32 | 20.2% |
About Dr. Daniel Parish, MD
Dr. Daniel Parish, MD is a Internal Medicine healthcare provider based in Bala Cynwyd, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/18/2007. The National Provider Identifier (NPI) number assigned to this provider is 1063608693.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Parish, MD has received a total of $1,283 in payments from pharmaceutical and medical device companies, with $393.02 received in 2024. These payments were reported across 63 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,151).
As a Medicare-enrolled provider, Parish has provided services to 8,540 Medicare beneficiaries, totaling 15,457 services with total Medicare billing of $667,315. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Bala Cynwyd, PA
- Active Since 09/18/2007
- Last Updated 01/29/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1063608693
Products in Payments
- TREMFYA (Drug) $248.89
- RINVOQ (Biological) $192.26
- ENSTILAR (Drug) $114.26
- SKYRIZI (Biological) $99.41
- HUMIRA (Biological) $95.12
- DUPIXENT (Drug) $60.37
- COSENTYX (Biological) $53.74
- PICATO (Drug) $48.13
- Otezla (Drug) $42.12
- EUCRISA (Drug) $39.45
- Sotyktu (Drug) $36.94
- DUPIXENT (Biological) $30.40
- DAXXIFY (Drug) $21.85
- DUPIXENT DUPILUMAB INJECTION (Biological) $20.67
- OPZELURA (Drug) $20.50
- CLODERM (Drug) $20.37
- ALTRENO (Drug) $19.91
- RETIN-A-MICRO (Drug) $19.74
- YCANTH (Drug) $18.54
- ORACEA (Drug) $16.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Bala Cynwyd
Dr. Mohammed Kidwai, Md, MD
Internal Medicine — Payments: $677,364
Internal Medicine $677,364
Dr. Janine Kyrillos, M.d, M.D
Internal Medicine — Payments: $170,038
Internal Medicine $170,038
Gerald Faich, Md, MD
Internal Medicine — Payments: $69,123
Internal Medicine $69,123
Dr. Robert Weiss, M D, M D
Internal Medicine — Payments: $5,419
Internal Medicine $5,419
Dr. Nancy Pickering, Md, MD
Internal Medicine — Payments: $3,840
Internal Medicine $3,840
Dr. Lauren Musser, Md, MD
Internal Medicine — Payments: $706.41
Internal Medicine $706.41